Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Endocrinol (Paris) ; 85(1): 36-43, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37574109

ABSTRACT

BACKGROUND AND AIMS: We describe mortality-related risk factors of inpatients with diabetes and coronavirus disease 2019 (COVID-19) in Belgium. METHODS: We conducted a multicenter retrospective study from March to May, 2020, in 8 Belgian centers. Data on admission of patients with diabetes and COVID-19 were collected. Survivors were compared to non-survivors to identify prognostic risk factors for in-hospital death using multivariate analysis in both the total population and in the subgroup of patients admitted in the intensive care unit (ICU). RESULTS: The study included 375 patients. The mortality rate was 26.4% (99/375) in the total population and 40% (27/67) in the ICU. Multivariate analysis identified older age (HR 1.05 [CI 1.03-1.07], P<0.0001) and male gender (HR 2.01 [1.31-3.07], P=0.0013) as main independent risk factors for in-hospital death in the total population. Metformin (HR 0.51 [0.34-0.78], P=0.0018) and renin-angiotensin-aldosterone system blockers (HR 0.56 [0.36-0.86], P=0.0088) use before admission were independent protective factors. In the ICU, chronic kidney disease (CKD) was identified as an independent risk factor for death (HR 4.96 [2.14-11.5], P<0.001). CONCLUSION: In-hospital mortality due to the first wave of COVID-19 pandemic in Belgium was high in patients with diabetes. We found that advanced age and male gender were independent risk factors for in-hospital death. We also showed that metformin use before admission was associated with a significant reduction of COVID-19-related in-hospital mortality. Finally, we showed that CKD is a COVID-19-related mortality risk factor in patients with diabetes admitted in the ICU.


Subject(s)
COVID-19 , Diabetes Mellitus , Metformin , Renal Insufficiency, Chronic , Humans , Male , COVID-19/epidemiology , Retrospective Studies , Belgium/epidemiology , Hospital Mortality , Inpatients , Pandemics , SARS-CoV-2 , Diabetes Mellitus/epidemiology , Risk Factors , Renal Insufficiency, Chronic/epidemiology
2.
BMC Infect Dis ; 20(1): 361, 2020 May 20.
Article in English | MEDLINE | ID: mdl-32434466

ABSTRACT

BACKGROUND: Neisseria meningitidis has rarely been described as an agent of necrotic soft tissue infection. CASE PRESENTATION: We report a case of a septic shock with necrotizing cellulitis due to Neisseria meningitidis serogroup W, treated by urgent extensive surgical debridement followed by skin grafts. The invasive meningococcal disease occurred together with a complement deficiency, possibly acquired after bypass surgery that took place 1 year before. CONCLUSIONS: Necrotic tissue infections should be considered part of the invasive meningococcal diseases spectrum and should prompt clinicians to look for complement deficiencies. Gastric bypass surgery associated malnutrition may be implicated but further verification is needed.


Subject(s)
Cellulitis/microbiology , Gastric Bypass/adverse effects , Meningococcal Infections/complications , Bacteremia/microbiology , Bacteremia/therapy , Cellulitis/etiology , Cellulitis/therapy , Complement System Proteins/deficiency , Debridement , Female , Humans , Meningococcal Infections/therapy , Middle Aged , Neisseria meningitidis , Shock, Septic/etiology , Shock, Septic/therapy , Soft Tissue Infections/etiology , Soft Tissue Infections/microbiology , Soft Tissue Infections/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...